Hearing loss is the most common sensorineural disorder worldwide and is associated with more than 1000 mutations in more than 90 genes. While mutations in genes such as GJB2 (gapjunction protein β 2) and GJB6 (gap-junction protein β 6) are highly prevalent in Caucasian, Asian, and Middle Eastern populations, they are rare in both native African populations and those of African descent. The objective of this paper is to review the current knowledge regarding the epidemiology and genetics of hearing loss in African populations with a focus on native sub-Saharan African populations. Environmental etiologies related to poor access to healthcare and perinatal care account for the majority of cases. Syndromic etiologies including Waardenburg, Pendred, and Usher syndromes are uncommon causes of hearing loss in these populations. Of the non-syndromic causes, common mutations in GJB2 and GJB6 are rarely 
Introduction
Hearing loss is the most common congenital sensorineural disorder worldwide, affecting about 1 in 1,000 children. In the US, genetic factors are responsible for approximately half of the cases of hearing loss (Mustapha et al., 2001) , of which 30% are associated with syndromic causes and 70% are considered non-syndromic hearing loss (NSHL) -i.e., deafness alone with no associated features suggesting a clinical syndrome (Van Camp et al., 1997) .
NSHL has been studied worldwide and more than 1000 mutations on over 90 genes have been identified, demonstrating that NSHL is highly heterogeneous (Van Camp et al., 1997; Van Camp and Smith, 2016) . Mutations in the GJB2 (gap-junction protein β 2) gene (13q11-q12) account for a high proportion of these cases in many populations and explain up to 50% of cases in the Mediterranean regions (Gasparini et al., 1997; Kelsell et al., 1997; Estivill et al., 1998) . Specific GJB2 mutations occur preferentially, but not exclusively, in distinct ethnic groups. The deletion variant g.3352GdelG (commonly designated c.30delG or c.35delG), for example, is by far the most frequent cause of autosomal recessive non-syndromic deafness among Caucasians (Zelante et al., 1997; Brobby et al., 1998; Kelley et al., 1998) . Other frequent population-specific GJB2 mutations include c.167delT in Ashkenazi Jews (Morell et al., 1998; Idan et al., 2013 ) and c.235delC in East Asians (Japanese, Koreans, and Chinese) (Abe et al., 2000; Park et al., 2000; Yan et al., 2003; Dai et al., 2009 ). On the other hand, the GJB6 (gap-junction protein β 6) deletion mutation del(GJB6-D13S1830) is common in France, Spain, the United Kingdom and There is therefore a need to identify genetic causes of hearing loss in populations of African descent. With recent developments in high-throughput sequence capture methods and nextgeneration sequencing (NGS), technologies now allow for the complete analysis of all known deafness-causing genes. Given the relative rarity of known deafness-causing genes in populations of African descent and the recent acceleration in identifying genetic causes of NSHL, the goal of the current paper is to review epidemiology, etiology, and genetic causes of deafness in African populations worldwide with a focus on indigenous African populations. We will then discuss current and future strategies to discover the genes responsible for deafness in African populations worldwide. A productive initial approach may be to describe the specific genetic causes of hearing loss in indigenous African populations with low foreign genetic admixture. Populations in Northern Africa have significant genetic admixture with European and Middle Eastern populations (Henn et al., 2012) ; we, therefore, will focus our attention on findings from populations in Sub-Saharan African, an area, which, despite European colonization, has remained relatively genetically isolated.
To identify the most relevant publications regarding the etiology of hearing loss in sub-Saharan Africa, we used the keywords 'hearing loss, deafness, genetics, sub-Saharan, and Africa,' in both PubMed and Google Scholar. We later expanded the search terms to include keywords for specific syndromes and genetic mutations. These search terms yielded numerous publications from 1966 to the present, and all applicable case series, reviews, and genetic studies were included. We included only publications with specific mention of indigenous African populations or populations of indigenous African descent in this manuscript as other populations have distinctly different genetic backgrounds from our population of interest. A summary of these papers is included in Table 1 . We excluded those studies that are not relevant to our topic such as those dealing with specific environmental etiologies, newborn hearing screening studies, and audiometry studies.
Our review includes 26 case reports, case series, reviews, and cross-sectional studies detailing the etiology of hearing loss for a total of roughly 10,500 patients with hearing loss of any cause, from Sub-Saharan Africa or of African descent. Collectively, 1.5% of these subjects had syndromic deafness, while 29.8% had suspected non-syndromic genetic deafness, and 68.7% Gambian 259 severe to profoundly deaf children aged 2-10 years. N/A Postnatally acquired hearing loss (i.e. infection, n = 167), congenital (n = 5), unknown (n = 81), other (n = 6) McPherson, 1985 Ghanaian 21 deaf subjects from 11 families GJB2
All affected subjects homozygous for GJB2 mutation p.R143W. 
Environmental causes of congenital deafness
Congenital hearing loss may be environmental or genetic. In developed countries with modern prenatal care and vaccination, deafness occurs in 1 in 1000 births with genetic forms of hearing loss being the leading cause of congenital deafness. In developing countries, however, the rate of deafness is 3 in 1000 births, with environmental causes continuing to be the main contributor to congenital hearing loss. In developing countries of Sub-Saharan Africa with predominantly indigenous African populations, this rate of congenital deafness is higher, 6 per 1000 births in South Africa and 7 per 1000 births in Nigeria for example, suggesting a higher burden of environmental deafness in these populations . This can be attributed to multiple factors in the perinatal and early childhood periods including limited healthcare access, lack of vaccination, maternal infection and malnutrition during pregnancy, birth trauma, and perinatal infections such as bacterial meningitis. With the current low rate of neonatal hearing screening in Africa, the resultant hearing loss may only be diagnosed months or years later, confounding the classification of the hearing loss into congenital or acquired.
In a study among 582 deaf patients in Cameroon to determine etiology, a review of family history including pedigree drawing and identification of consanguinity, and a comprehensive retrospective chart review were performed. The results attributed the majority of cases (53%) to environmental causes, 15% to genetic components, and the remaining 32% to unknown causes.
Of those cases due to genetics, 13% were attributed to a syndromic form of hearing loss (Wonkam et al., 2013) .
Similar findings were seen in a study of 259 Gambian hearing impaired children aged from 2 to 10 years. Based on a detailed birth, medical, and family history, the study demonstrated that environmental exposure to illness accounted for the majority of cases, with nearly 32% attributed to meningitis or meningitis-like symptoms and an additional 25% to other common childhood illness (e.g., rubella, fever). Genetic factors contributed to a low 8% of the cases and for the remainder the etiologies were unknown (McPherson and Holborow, 1985) .
However, both of these studies relied heavily on clinical history rather than medical testing, perhaps underestimating the number of cases due to genetic factors. This high rate of environmental deafness compounded with a lack of complete medical records has complicated the task of deciphering the genetic contribution to congenital hearing loss in African populations.
The impact of cultural and social practices
The reliance on traditional forms of healing and on traditional healers has at times delayed patients from seeking formal medical attention in a timely fashion. For example, seeking tribal medicine for a child with a fever due to meningitis will delay the administration of suitable antibiotics, leading to sequelae such as deafness.
Single parent homes and disruption of family structures due to migratory labor practices are both commonplace in many parts of sub-Saharan Africa. Children are then brought up by single mothers, grandparents or other relatives. While taking a medical history, valuable information may be unknown to the primary caregiver and therefore may be missed. On the other hand, the discouragement of close family mating and consanguineous mating among sub-Saharan populations protects against the clustering of defective genes in the population.
Syndromic deafness
Among cases of genetic or familial hearing loss, several syndromic conditions have been encountered in Sub-Saharan Africa. As early as 1977, Sellars and Beighton studied 499 deaf black children from three special schools for the deaf in Transkei, Ciskei, and the eastern Orange
Free State of Southern Africa and identified 21 children aged 6 to 18 years with genetic syndromes. Based on clinical and otologic examinations, researchers identified Waardenburg (n = 13), vitiligo deafness (n = 2), treacher collins (n = 2), Hunters (n = 1), Crouzon's (n = 1), Pendred's (n = 1), and trichorhinophalangeal (n = 1) syndromes (Sellars, 1977) . Additional reports of syndromic deafness in Sub-Saharan Africa include cases of Usher's, Pierre Robinson, and Leopard syndromes (le Roux et al., 2015) . While these syndromes account for the majority of syndromic hearing loss cases in the developed world, they are infrequent causes of hearing loss in African populations and are not considered to be strong risk factors for hearing loss in these populations (Friderichs et al., 2012) .
Waardenburg syndrome (WS)
Waardenburg syndrome is a group of genetic conditions that cause pigmentation changes in the hair, skin, and eyes, and has been noted as the most common cause of syndromic hearing loss in Sub-Saharan populations . However, it still only accounts for approximately 3%-5% of genetic cases (Beighton et al., 1991) . In 1983, Sellers and Beighton evaluated 3006 school children and identified 90 (3.0%) as having Waardenburg Syndrome. This study included 1226 indigenous African children, of whom 33 were affected (2.7%) (Sellars and Beighton, 1983 ). Waardenburg Syndrome typically follows an autosomal dominant inheritance pattern;
however, a number of de novo cases have been described in a Cameroonian cohort .
Usher syndrome (USH)
Usher syndrome is clinically characterized by hearing loss and retinitis pigmentosa. It has three clinical subtypes and is a common cause of combined hearing loss and blindness worldwide. To date, 11 genes have been associated with USH, with numerous autosomal recessive mutations reported in USH1C, MYO7A, and CDH23 . USH is less common in SubSaharan Africa, representing only 1%-2% of genetic cases; however, researchers recently described a rare c.6377delC (p.Pro2126Leufs*5) mutation in the MYO7A gene in two unrelated
African individuals. Further analysis revealed that this is the causative mutation in 12 additional
African individuals with hearing loss. This particular mutation has only been reported once before in a heterozygous Caucasian individual (Roberts et al., 2015) .
Pendred syndrome
Pendred syndrome is a form of sensorineural hearing loss (SNHL) associated with thyroid goiter that accounts for <1% of genetic causes of hearing loss in Sub-Saharan Africa (Beighton et al., 1991; Wonkam et al., 2013 ). There are rare case reports in the literature, with the first cases in Africa described by Levin and Glugman in 1966 in two South African Bantu brothers (Levin and Klugman, 1966) .
Additionally, there have been case studies describing less frequently encountered syndromes . Two cases of Goldenhar, or oculo-auriculo-vertebral, syndrome have been described in a 3-day-old child in Nigeria (Adeoye, 2002 ) and a 15-month-old child in South
Africa (Naidoo and Stephen, 1998) . The genetics of this syndrome is not well understood, and its inheritance is believed to be multifactorial. Though only about 100 cases have been reported worldwide, several cases of keratitis-ichthyosis-de afness (KID) syndrome, defined by cornea, skin, and hearing abnormalities, have been described in Sub-Saharan Africa including Togo (Barruet et al., 2011; Kombate et al., 2015) and Cameroon. In Cameroon, two unrelated patients, ages 5 and 2, were found to have a sporadic p.Asp50Asn mutation in the GJB2 gene, previously described only in a single African patient from the Emirates (Wonkam et al., 2013) .
Additionally, a set of African monozygotic twins, one referred at birth and one at 3 months, have been described with a p.Gly45Glu (G45E) mutation in the GJB2 gene, coding for a lethal form of the disease within the first year of life (Jonard et al., 2008 ). The extremely rare Leopard syndrome, due to a defect in the protein tyrosine phosphatase non-receptor 11 gene (PTPN 11) on chromosome 12, is characterized by abnormalities of the skin, heart, and ear and has been described in one 6-year-old Djiboutian boy (Massour e et al., 2012).
Non-syndromic deafness
Non-syndromic hearing impairment accounts for the majority of inherited hearing loss, approximately 70%. In the US, autosomal-recessive inheritance is responsible for about 80% of cases of non-syndromic hearing impairment, while autosomal-dominant genes cause 20%, and less than 2% of cases are caused by X-linked and mitochondrial genetic malfunctions.
Comprehensive review of the relatively sparse literature of NSHL in populations of African descent shows 12 different pathogenic genes, including 34 different pathogenic or likely pathogenic mutations in 159 individuals with a confirmed etiology of genetic NSHL (Table 2) . Human et al., 2010 *The mutation frequency is calculated based on this review of the literature. It is not a reported value from the original publications. ** n = number of subjects with a mutation in the gene of interest identified in review of the literature.
# hom, homogeneous mutation; ## het, heterogeneous mutation; ### comp het, composite heterozygous mutation; HL, hearing loss.
GJB2
Mutations of GJB2 are the most common cause of non-syndromic genetic deafness worldwide in non-African populations. Specific mutations are associated with specific populations: c.35delG
in Europeans, c.167delT in Ashkenazi Jews, c.235delC in East Asians. In contrast, the few studies available suggest that GJB2 is not a major cause of deafness in most African populations studied to date.
With the notable exception of Ghana (Chan and Chang, 2014) , GJB2 has not been found to be a prominent genetic cause of hearing loss in sub-Saharan Africa. We have previously shown that none of the reported deafness-causing mutations in GJB2 nor any novel pathogenic mutations in the coding region were detected in an indigenous African population of the Limpopo Province of South Africa. The GJB6-D13S1830 deletion and the mitochondrial mutations were also not observed in this group (Kabahuma et al., 2011) . GJB2 mutations were also absent among deaf probands from the Yoruba tribe residing in Ibadan, a suburban city in Nigeria (Lasisi et al., 2014) . Similarly, an analysis of a large cohort of Ugandan deaf patients identified none of the common GJB2 deletions (Javidnia et al., 2014) . Despite low rates of common GJB2 mutations in the Ugandan population, complete sequencing of 115 of the 126 individuals revealed one pathogenic variant in GJB2 (c.208C>G; p.Pro70Ala) (Javidnia et al., 2014) . Analysis of the coding region of the GJB2 gene in 205 Cameroonian and Xhosa South Africans with congenital, non-syndromic deafness, also revealed low frequencies of common mutations but identified two monoallelic pathogenic mutations (p.F142del and p.V167M) in two unrelated Cameroonian participants (Bosch et al., 2014) .
Most African populations do not show a high prevalence of GJB2 mutations. However, there is one specific GJB2 mutation, p.R143W (c.427C>T), with a relatively high prevalence in the Ghanaian population of the Adamorobe village, an inbred community (Hamelmann et al., 2001 ).
These individuals presented with severe to profound bilateral congenital SNHL. Secondly, other GJB2 variants have been identified in 12.7% and 6.5% of Kenyan and Sudanese deaf persons, respectively. Collectively, the population's hearing loss is described as bilateral, sensorineural, non-syndromic, pre-lingual, and of severe to profou nd severity; hearing characteristics of specific variants are not described. 42.6% of a normal hearing control group, respectively, suggesting that these are common nonpathogenic polymorphisms (Kabahuma et al., 2011) . These variants were also found with high frequency in populations from Cameroon, Uganda, Kenya, and Sudan, supporting their role as benign polymorphisms (Gasmelseed et al., 2004; Bosch et al., 2014; Javidnia et al., 2014) .
Interestingly, the c.35delG mutation, common in Europeans, has been identified in 5/139
Sudanese deaf children and 1/100 Afro-Brazilians. In both cases, it has been suggested that the presence of this mutation is from genetic admixture with European populations rather than inherent in each population (Gasparini et al., 2000; Gasmelseed et al., 2004) .
The c.35delG mutation is also rare among African American populations. Gaparini et al. (2000) assessed the carrier frequency of the c.35delG mutation in various populations, including 190
African Americans, and did not identify any carriers in this cohort. Another study examined 173 non-deaf African Americans for the c.35delG variant and 171 non-deaf African Americans for the 167delT variant and did not identify any carriers for either, suggesting that these alleles are of very low frequency (Morell et al., 1998) .
One study identified GJB2 pathologic variants in 4% of 50 African American deaf patients, as compared to 26% of Caucasians and 11% of Hispanics in the same study, with c.35delG as the most common mutation in all ethnicities . However, most deafness-causing genes in African individuals within the United States have yet to be identified.
Overall, more than 30 variants in the GJB2 gene have been described in deaf patients of African descent. Approximately 13 are thought to be pathogenic or likely pathogenic. These mutations along with their frequencies, if available, are listed in Table 2 . Among them, 78% of all pathogenic or likely pathogenic NSHL mutations in populations of African descent included in this review are found on GJB2. However, much of this contribution is from the Ghanaian population alone. If Ghana is excluded, GJB2 mutations comprise only 37.3% of NSHL mutations in this review, with most studied populations of African descent having a complete absence of pathogenic GJB2 mutations.
GJB6
The most common mutation in GJB6 is the 342-kb GJB6-D13S1830 deletion, which causes NSHL when homozygous, or when present on the opposite allele of a GJB2 mutation. The GJB6-D13S1830 mutation, which is most frequent in Spain, France, the United Kingdom, Israel and Brazil (5.9%-9.7% of all DFNB1 alleles), is les s frequent in the USA, Belgium and Australia (1.3%-4.5% of all DFNB1 alleles), and ver y rare in Southern Italy (Del Castillo et al., 2003) . In Northern Italy, frequencies are similar to those of other European countries.
Studies among African populations reported that pathologic GJB6 mutations have been widely screened but not identified. Specifically, they were found to be absent in African populations within South Africa (Kabahuma et al., 2011) , Nigeria (Lasisi et al., 2014) , Cameroon (Bosch et al., 2014) , Brazil (Batissoco et al., 2009 ) and the United States Samanich et al., 2007) . proportion of the South African population is genetically predisposed to developing aminoglycoside-induced hearing loss. The 961 delT+insC(n) (7.1% of Black controls) and m.961T>G (2.9% of Afrikaner controls) variants were found at frequencies ranging from 1.1% to 7.1%. However, the incidence of ototoxicity in the MDR-TB patients harboring these mutations is not discussed in the review.
In those black patients for whom aminoglycoside induced ototoxicity was confirmed, researchers additional studies, suggesting a pathologic role in hearing loss (Trotta et al., 2011) .
Overall, mutations on MTRNR1 account for 11.2% of NSHL in populations of African descent included in this review, with the m.1555A>G mutation comprising 70% of these mutations (7.8% of mutations in this study).
MYO3A
Several recessive, loss of function mutations in MYO3A causing hearing loss have been Mutational analysis revealed a single novel variant, p.Gly488Glu, in the MYO3A gene (Grati et al., 2016) . MYO3A is responsible for 1.7% of mutations in populations of African descent included in this review.
Application of next-generation sequencing (NGS) in non-syndromic hearing loss
NGS is rapidly expanding the knowledge of non-syndromic genetic deafness, particularly in previously under-studied populations. In use since the late 1990s, NGS encompasses several techniques of genome sequencing that produce thousands or millions of parallel and overlapping DNA sequences that allows for rapid and relatively inexpensive analysis of large segments of DNA.
As part of a recent multi-ethnic genetic deafness study, two deaf indigenous GJB2-negative subSaharan African populations were tested for genetic deafness using an NGS custom capture panel (MiamiOtoGenes, USA) (Yan et al., 2016) . The study included 91 indigenous deaf persons from the Limpopo province of South Africa and 90 from the Yoruba tribe in Ibadan, Nigeria.
Tunisia, a north African country, was also included in their study but will not be included in this discussion as the ethnic admixture in Tunisia is significantly higher given its European and Arabic genetic contribution. Two issues must be clarified if one is to make logical conclusions from this data. One, all the deaf probands were recruited by experienced and highly trained otolaryngologists who are based in those countries (South Africa and Nigeria), and who understand both the cultures and the languages of the local people. Second, based on the foregoing, it can be accepted that all these deaf individuals were correctly assessed and that environmental causes for the hearing loss were excluded, leaving only genetic causes for the hearing loss as reported. From these observations, it therefore becomes apparent that the high number of unsolved cases are all due to a genetic cause whose genes and mutations have either not yet been identified or fall outside of the gene pool included in the gene panel used in this study.
To support this conclusion, it is notable that the unsolved cases from the countries that practice consanguineous mating or where inbreeding is prevalent, such as Tunisia, India, Iran, and Turkey, were found mainly in the multiplex families. The sub-Saharan communities in South Africa and Nigeria, where the deaf probands were recruited, discourage consanguineous mating.
When one considers that large endogamous populations were instrumental in mapping genes for NSHL (Keats and Berlin, 1999) , and the extreme heterogeneity of genetic hearing loss, these findings are to be expected. In the sub-Saharan populations, natural spread of mutations and variations is expected, leading to a larger number of simplex cases compared to multiplex cases.
A high number of de novo mutations are therefore to be expected. The reverse holds for inbred communities where clustering of mutations occurs due to inbreeding and consanguineous mating. Recessive genetic defects will cluster in the latter communities, as exemplified by the founder effect.
Despite these limitations, this was the first study to successfully identify several likely pathogenic deafness-causing variants in sub-Saharan populations (Yan et al., 2016) .
Additionally, several other genes found to have VUS in these South African and Nigerian populations will require further investigation.
Future work
Deafness research in Africa has long lagged behind the developed world due to lack of diligent medical records, poor access to health care, limited infrastructure, low number of skilled workers along with the outflow of skilled researchers to developed countries, funding, and limited access to high-impact journals for relatively lesser-known African researchers. Additionally, the environmental impact on deafness and the widespread avoidance of consanguinity in African societies, further minimize the genetic contributions to disease (McPherson and Swart, 1997) and increase the burden of genetic data needed for pathologic mutation identification. However, genetic deafness research in populations of African descent has advanced tremendously over the last two decades with the advent of NGS and the increasing level of collaboration between African universities with genetic research centers abroad.
South Africa is addressing the issue of poor continuity of patient care in Africa as well as the suboptimal medical records by the development of a unique healthcare identifier system, currently in its pilot phase. In this system, the patient will retain a unique identifier throughout life and his or her medical records are accessible in all public hospitals nationally. The anticipated effects in medical management, patient tracing, and clinical research are expected to be transforming.
Common variants responsible for genetic deafness in populations are not common in individuals of African descent; in fact, some authors argue that there is no clinical utility in screening for GJB2, GJB6, or GJA1 in black Africans . Recent work by Yan et al (2016) showed promising use of a large screening deafness gene panel (MiamiOtoGenes) for detecting rare or novel mutations in a rapid and cost-effective manner. In patients shown to be negative for GJB2, GJB6, and mitochondrial mutations, NGS with the MiamiOtoGenes panel revealed several candidate deafness genes for the first time in sub-Saharan African populations (Nigeria and Limpopo, South Africa).
In those patients for whom a diagnosis is still not obtained, whole-exome sequencing or even whole-genome sequencing is then the next step. This type of sequential genetic screening approach will become increasingly important for both research and clinical applications. Much work remains to elucidate the genetic causes of hearing loss in populations of African descent worldwide, but with the development of NGS and efficient deafness gene-screening protocols, the present and future of genetic deafness research has never looked brighter.
Conclusion
Globally, acquired causes of hearing loss remain the predominant etiology of hearing loss in patients of African descent. With improved preventative care, including vaccination and perinatal care, genetic causes of hearing loss will take on a larger proportion of the hearing loss burden in this population. 
